Showing results (1061-1070 of 3,525) with videos related to

Sort By:
Pageof 353
Thoracic Cancer|August 20, 2019
Primary pulmonary synovial sarcoma with calcification: A case reportHironori Ishida, Takashi Fujino, Ryo Taguchi, et al.
Thoracic Cancer|August 23, 2019
Risk factors and cancer recurrence associated with postoperative complications after thoracoscopic lobectomy for clinical stage I non-small cell lung cancerTakeo Nakada, Yuki Noda, Daiki Kato, et al.
Thoracic Cancer|February 28, 2019
Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non-small cell lung cancer patientsAyako Shiono, Kyoichi Kaira, Atsuto Mouri, et al.
Thoracic Cancer|February 28, 2019
Clinical and computed tomography characteristics of non-small cell lung cancer with ALK gene rearrangement: Comparison with EGFR mutation and ALK/EGFR-negative lung cancerMio Mori, Hideyuki Hayashi, Minoru Fukuda, et al.
Thoracic Cancer|February 19, 2019
Chemotherapy combined with Endostar as salvage treatment for EGFR-tyrosine kinase inhibitor primary resistance in an advanced non-small cell lung cancer patient with EGFR L858R mutation and ROS1 fusion: A case reportDong Qiu, Yu Zhang, Ying-Bo Xue, et al.
Thoracic Cancer|February 20, 2019
Malignant pleural effusion supernatant is an alternative liquid biopsy specimen for comprehensive mutational profilingZhihua Guo, Zhanhong Xie, Huifang Shi, et al.
Thoracic Cancer|February 20, 2019
Curative effect assessment of immunotherapy for non-small cell lung cancer: The "blind area" of Immune Response Evaluation Criteria in Solid Tumors (iRECIST)Peng Song, Jingcheng Zhang, Congcong Shang, et al.
Thoracic Cancer|November 24, 2018
Intrapulmonary lymph node metastasis is common in clinically staged IA adenocarcinoma of the lungDengGuo Zhang, XianChao Chen, Daxin Zhu, et al.
Thoracic Cancer|January 22, 2021
Upregulation of SIX4 indicates poor clinical outcome and promotes tumor growth and cell metastasis in esophageal squamous cell carcinomaYanping Li, Xiaomei Jiang, Xiaoyan Yan, et al.
Thoracic Cancer|January 25, 2021
Tofacitinib overcomes an IFNγ-induced decrease in NK cell-mediated cytotoxicity via the regulation of immune-related molecules in LC-2/adRiki Okita, Katsuhiko Shimizu, Yuji Nojima, et al.
Pageof 353